U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 20:32:32 GMT 2025
Edited
by admin
on Mon Mar 31 20:32:32 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
47RRR83SK7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SH-POLYPEPTIDE-46
INCI  
INCI  
Preferred Name English
INTERFERON ALFA-2A
MI   USAN   VANDF   WHO-DD  
USAN  
Official Name English
INTERFERON-ALFA-2A
Common Name English
RO-228181
Code English
INTERFERON ALFA-2A [MI]
Code English
ROFERON-A
Brand Name English
CANFERON
Brand Name English
RO 22-8181
Code English
INTERFERON ALFA-2A, RECOMBINANT
Common Name English
RECOMBINANT HUMAN INTERFERON-ALFA-2A [EMA EPAR]
Common Name English
INTERFERON ALFA-2A [VANDF]
Common Name English
Interferon ?A (human leukocyte protein moiety reduced)
Common Name English
RECOMBINANT HUMAN INTERFERON ALFA-2A
Common Name English
INTERFERON ALFA-2A,RECOMBINANT
VANDF  
Common Name English
INTERFERON ALFA-2A [JAN]
Common Name English
INTERFERON ALFA-2A,RECOMBINANT [VANDF]
Common Name English
RO-22-8181
Code English
Interferon alfa-2a [WHO-DD]
Common Name English
ALPHEON
Brand Name English
INTERFERON ALPHA-2A
Common Name English
ROFERON A
Brand Name English
CHA-IFNALPHA2A
Brand Name English
CANFERON A
Brand Name English
INTERFERON ALFA-2A [USAN]
Common Name English
INTERFERON ALFA-2A (RECOMBINANT)
Common Name English
RECOMBINANT HUMAN INTERFERON-ALFA-2A
EMA EPAR  
Common Name English
Classification Tree Code System Code
NDF-RT N0000006291
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006291
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
FDA ORPHAN DRUG 44590
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
WHO-VATC QL03AB04
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006710
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
FDA ORPHAN DRUG 44690
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006291
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
FDA ORPHAN DRUG 25987
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
FDA ORPHAN DRUG 36989
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006291
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
WHO-ATC L03AB04
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
FDA ORPHAN DRUG 27488
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
FDA ORPHAN DRUG 40889
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006291
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006710
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
FDA ORPHAN DRUG 42389
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006291
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000175521
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006710
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
NDF-RT N0000006291
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
EMA ASSESSMENT REPORTS ALPHEON (REFUSED: HEPATITIS C, CHRONIC)
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
Code System Code Type Description
MERCK INDEX
m6304
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY Merck Index
DRUG BANK
DB00034
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
UNIPROT
P01563
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
CAS
77907-69-8
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
ALTERNATIVE
EVMPD
SUB126474
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
CAS
76543-88-9
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
FDA UNII
47RRR83SK7
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
USAN
T-64
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
EPA CompTox
DTXSID8031449
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
IUPHAR
4960
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
MESH
C554043
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
RXCUI
5879
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY RxNorm
NCI_THESAURUS
C1952
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
SMS_ID
100000091638
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108508
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
EVMPD
SUB12447MIG
Created by admin on Mon Mar 31 20:32:32 GMT 2025 , Edited by admin on Mon Mar 31 20:32:32 GMT 2025
PRIMARY
Related Record Type Details
Structure of DEUCRAVACITINIB
INHIBITOR -> TARGET
INTERFERON STIMULATED REPORTER GENE ASSAY
DOWNSTREAM INHIBITOR
Structure of BMS-986202
INHIBITOR -> TARGET
Other IFN?'s should also be inhibited. IFN? stimulated luciferase reporter assay in Kit225 T cells.
DOWNSTREAM INHIBITOR
IC50
PEGINTERFERON ALFA-2A
CONJUGATE->CONJUGATE COMPONENT
Related Record Type Details
INTERFERON ALFA-2A
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966